The colectomy-focused surgical device developer, which counts SinoPharm as an earlier investor, has secured series B-plus funding, in a round led by Bluestem Capital.

Citi Ventures joined Roofstock’s shareholders in a series D round that increased the property investment platform's overall funding to $133m.

Novo Seeds returned for a series B round that will support the progress of NorthSea Therapeutics' lead liver disease candidate through clinical trials.

The eye disease drug developer has closed a round led by existing backer Boehringer Ingelheim Venture Fund to take its total funding above $42m.

Paris Descartes University's gene therapy developer has raised $42.1m altogether following a series B featuring existing investors including Inserm Transfert Initiative.

RXR Realty invested in apartment rental service The Guild as part of a round that brought the latter's overall funding to more than $36m.

Hesai has raised what it claims to be the largest ever funding round for a lidar technology producer, with Robert Bosch a key investor.

Samsung, SIG and OP Financial contributed to $144m in funding, raised across two rounds, for digital health technology producer Zhiyun Health.

Citi Ventures and Susquehanna Growth Equity both returned for the business accounting software provider’s series B round, which enabled it to achieve a unicorn valuation.

Itochu returned to help the electric vehicle leasing service raise tens of millions of dollars, seven months after it closed a $100m series B round.